Zai Lab Ltd (ZLAB) income statement
ZLABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30421% above fair value
$22.11−1.42 (-6.03%)
Close on Nov 18, 2026Market cap $3.43BP/E –Yield –
Zai Lab Ltd income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 56.5%
- Operating margin
- -58.7%
- Net margin
- -41.9%
- Return on equity, FY2025
- -22.6%
Financial strength
- Current ratio
- 2.13
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 141.8%
Valuation
- P/E ratio
- –
- Price to sales
- 7.64
- Price to book
- 5.66
- Dividend yield
- –
See a number that looks wrong?